OSE Immunotherapeutics SA
PAR:OSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
Sanoma Oyj
F:SNQB
|
FI |
|
D
|
Dream Us Co
KOSDAQ:060570
|
KR |
|
Asuransi Ramayana Tbk PT
IDX:ASRM
|
ID |
|
Lucara Diamond Corp
TSX:LUC
|
CA |
|
D
|
Despec Bilgisayar Pazarlama ve Ticaret AS
IST:DESPC.E
|
TR |
|
Salesforce Inc
NYSE:CRM
|
US |
|
Lifeist Wellness Inc
XTSX:LFST
|
CA |
|
Clearfield Inc
NASDAQ:CLFD
|
US |
|
S
|
Seres Therapeutics Inc
SWB:1S9
|
US |
|
A
|
Allup Silica Ltd
ASX:APS
|
AU |
|
Kinatico Ltd
ASX:KYP
|
AU |
|
N
|
Nissui Corp
SWB:71N
|
JP |
|
S
|
Shagrir Group Vehicle Services Ltd
TASE:SHGR
|
IL |
|
C
|
Capstone Green Energy Corp
F:TBN2
|
US |
|
Lifecare AS
OSE:LIFE
|
NO |
|
Blackfinch Spring VCT PLC
LSE:BFSP
|
UK |
|
Crescent Biopharma Inc
F:C68
|
US |
|
R
|
Rock Edge Resources Ltd
CNSX:REDG
|
CA |
|
Lotus Resources Ltd
ASX:LOT
|
AU |
|
SOL SpA
MIL:SOL
|
IT |
|
B
|
Bhilwara Spinners Ltd
BSE:514272
|
IN |
|
Barito Pacific Tbk PT
F:OB8
|
ID |
|
M
|
Merdeka Gold Resources PT Tbk
IDX:EMAS
|
ID |
Bankruptcy Probability
OSE Immunotherapeutics SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OSE Immunotherapeutics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
OSE Immunotherapeutics SA
PAR:OSE
|
68.4m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OSE Immunotherapeutics SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OSE Immunotherapeutics SA has total debt of 32.5m EUR. This includes both short-term (0 EUR) and long-term (32.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.
